학술논문
Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in 'suboptimal' patients with advanced gastric cancer (AGC). TTD 08-02.
Document Type
Academic Journal
Author
Source
Subject
Language
English
ISSN
0344-5704